A Phase II, Non-randomized, Open-label, Single-center Study to Evaluate the Efficacy and Safety of Erlotinib in Combination With Cisplatin based Chemoradiotherapy in Patients with Locally Advanced Cervical Cancer.
Phase of Trial: Phase II
Latest Information Update: 10 Nov 2015
At a glance
- Drugs Erlotinib (Primary) ; Cisplatin
- Indications Cervical cancer
- Focus Therapeutic Use
- 10 Nov 2015 New trial record